Botox Intervention Improves Facial Asymmetry After Nerve Damage
By Elana Gotkine HealthDay Reporter
TUESDAY, March 18, 2025 -- For patients with severe oral commissure droop from facial nerve damage undergoing surgery, botulinum toxin type A (BoNT-A) treatment helps to alleviate muscle hyperactivity, leading to improvement in facial asymmetry, according to a study published in the March issue of Plastic and Reconstructive Surgery.
Hao Ma, M.D., from Shanghai Ninth People's Hospital, and colleagues examined the impact of BoNT-A treatment on the unaffected side in 38 patients with severe oral commissure droop from facial nerve damage with respect to facial symmetry and brain connectivity. Participants were divided into two groups: those who did and did not receive BoNT-A injections on the unaffected side (20 and 18 patients, respectively).
The researchers found that BoNT-A treatment improved facial symmetry and induced significant modifications in brain functional network connectivity. The modifications extended beyond the sensorimotor network, involving high-level cognitive processes. There was a significant correlation between functional network connectivity and the degree of asymmetry.
"BoNT-A treatment appears to promote significant modifications in functional brain network connectivity, thereby sustaining the positive effects of BoNT-A," the authors write. "Our findings imply that the facial asymmetry is linked to the characteristics of large-scale functional networks."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Female PCPs Have Equal/Better Quality Outcomes Than Male PCPs
TUESDAY, May 20, 2025 -- Female primary care physicians (PCPs) in value-based payment models have equal or better quality outcomes and higher earning than their male counterparts...
Stereotactic Body Radiotherapy Feasible After Radical Prostatectomy
TUESDAY, May 20, 2025 -- Post-radical prostatectomy (post-RP) stereotactic body radiotherapy (SBRT) is well tolerated, with patient-reported outcomes (PROs) comparable to those...
Accurate Risk Prediction Model Developed for Pediatric Pneumonia
TUESDAY, May 20, 2025 -- An accurate risk prediction model has been developed for children younger than 14 years with community-acquired pneumonia (CAP), according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.